EGFR/B7H3 CAR-T therapy

CAR-T cells targeting EGFR and B7H3 · Second Affiliated Hospital of Guangzhou Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EGFR/B7H3 CAR-T therapy, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: EGFR/B7H3 CAR-T on Lung Cancer and Triple Negative Breast Cancer [EARLY_Phase 1]